BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Italiano A, Chen CL, Thomas R, Breen M, Bonnet F, Sevenet N, Longy M, Maki RG, Coindre JM, Antonescu CR. Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics. Cancer 2012;118:5878-87. [PMID: 22648906 DOI: 10.1002/cncr.27614] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Riddell M, Nakayama A, Hikita T, Mirzapourshafiyi F, Kawamura T, Pasha A, Li M, Masuzawa M, Looso M, Steinbacher T, Ebnet K, Potente M, Hirose T, Ohno S, Fleming I, Gattenlöhner S, Aung PP, Phung T, Yamasaki O, Yanagi T, Umemura H, Nakayama M. aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability. Nat Commun 2018;9:5357. [PMID: 30559384 DOI: 10.1038/s41467-018-07739-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
2 Lin C, Ducis K, Tucker S, Tranmer B. Metastatic Cardiac Angiosarcoma to the Lung, Spine, and Brain: A Case Report and Review of the Literature. World Neurosurgery 2017;107:1049.e9-1049.e12. [DOI: 10.1016/j.wneu.2017.08.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Musa J, Orth MF, Dallmayer M, Baldauf M, Pardo C, Rotblat B, Kirchner T, Leprivier G, Grünewald TGP. Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis. Oncogene 2016;35:4675-88. [DOI: 10.1038/onc.2015.515] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 10.2] [Reference Citation Analysis]
4 Salter DM, Griffin M, Muir M, Teo K, Culley J, Smith JR, Gomez-Cuadrado L, Matchett K, Sims AH, Hayward L, Henderson NC, Brunton VG. Development of mouse models of angiosarcoma driven by p53. Dis Model Mech 2019;12:dmm038612. [PMID: 31221668 DOI: 10.1242/dmm.038612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Hung GY, Yen CC, Horng JL, Liu CY, Chen WM, Chen TH, Liu CL. Incidences of Primary Soft Tissue Sarcoma Diagnosed on Extremities and Trunk Wall: A Population-Based Study in Taiwan. Medicine (Baltimore) 2015;94:e1696. [PMID: 26469906 DOI: 10.1097/MD.0000000000001696] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
6 Amaya CN, Bryan BA. Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumors. BMC Clin Pathol 2015;15:18. [PMID: 26412983 DOI: 10.1186/s12907-015-0018-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hakozaki M, Ito S, Fujii T, Kiya Y, Udagawa H, Fukayama M, Fukusato T. Combined hepatocellular-cholangiocarcinoma with angiosarcomatoid change: A case report with immunohistochemical study: cHCC-CCA with angiosarcomatoid change. Pathol Int 2019;69:110-6. [DOI: 10.1111/pin.12755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kim JH, Lee JS, Kim EJ, Park KH, Kim KH, Yi SY, Kim HS, Cho YJ, Shin KH, Ahn JB, Hu H, Kim KS, Choi YD, Kim S, Lee YH, Suh JS, Noh SH, Rha SY, Kim HS. Prognostic implications of PIK3CA amplification in curatively resected liposarcoma. Oncotarget 2016;7:24549-58. [PMID: 27016421 DOI: 10.18632/oncotarget.8240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Shustef E, Kazlouskaya V, Prieto VG, Ivan D, Aung PP. Cutaneous angiosarcoma: a current update. J Clin Pathol 2017;70:917-25. [PMID: 28916596 DOI: 10.1136/jclinpath-2017-204601] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
10 Weidema M, Versleijen-jonkers Y, Flucke U, Desar I, van der Graaf W. Targeting angiosarcomas of the soft tissues: A challenging effort in a heterogeneous and rare disease. Critical Reviews in Oncology/Hematology 2019;138:120-31. [DOI: 10.1016/j.critrevonc.2019.04.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
11 De Felice F, Moscatelli E, Orelli S, Bulzonetti N, Musio D, Tombolini V. Primary thyroid angiosarcoma: A systematic review. Oral Oncology 2018;82:48-52. [DOI: 10.1016/j.oraloncology.2018.05.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
12 Brandt LP, Albers J, Hejhal T, Pfundstein S, Gonçalves AF, Catalano A, Wild PJ, Frew IJ. Mouse genetic background influences whether HrasG12V expression plus Cdkn2a knockdown causes angiosarcoma or undifferentiated pleomorphic sarcoma. Oncotarget 2018;9:19753-66. [PMID: 29731980 DOI: 10.18632/oncotarget.24831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Papke DJ, Hornick JL. What is new in endothelial neoplasia? Virchows Arch 2020;476:17-28. [DOI: 10.1007/s00428-019-02651-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
14 Venkataramani V, Küffer S, Cheung KCP, Jiang X, Trümper L, Wulf GG, Ströbel P. CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas. Clin Cancer Res 2018;24:460-73. [PMID: 29084920 DOI: 10.1158/1078-0432.CCR-17-1778] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
15 Movva S, Wen W, Chen W, Millis SZ, Gatalica Z, Reddy S, von Mehren M, Van Tine BA. Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets. Oncotarget 2015;6:12234-47. [PMID: 25906748 DOI: 10.18632/oncotarget.3498] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 13.2] [Reference Citation Analysis]
16 Ray-coquard IL, Domont J, Tresch-bruneel E, Bompas E, Cassier PA, Mir O, Piperno-neumann S, Italiano A, Chevreau C, Cupissol D, Bertucci F, Bay J, Collard O, Saada-bouzid E, Isambert N, Delcambre C, Clisant S, Le Cesne A, Blay J, Penel N. Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial. JCO 2015;33:2797-802. [DOI: 10.1200/jco.2015.60.8505] [Cited by in Crossref: 99] [Cited by in F6Publishing: 44] [Article Influence: 16.5] [Reference Citation Analysis]
17 Wada M, Horinaka M, Yasuda S, Masuzawa M, Sakai T, Katoh N. PDK1 is a potential therapeutic target against angiosarcoma cells. Journal of Dermatological Science 2015;78:44-50. [DOI: 10.1016/j.jdermsci.2015.01.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
18 Kaur A, Didolkar MS, Thomas A. Angiosarcoma of the thyroid: a case report with review of the literature. Endocr Pathol 2013;24:156-61. [PMID: 23794134 DOI: 10.1007/s12022-013-9253-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
19 Chan JY, Lim JQ, Yeong J, Ravi V, Guan P, Boot A, Tay TKY, Selvarajan S, Md Nasir ND, Loh JH, Ong CK, Huang D, Tan J, Li Z, Ng CC, Tan TT, Masuzawa M, Sung KW, Farid M, Quek RHH, Tan NC, Teo MCC, Rozen SG, Tan P, Futreal A, Teh BT, Soo KC. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma. J Clin Invest 2020;130:5833-46. [PMID: 33016928 DOI: 10.1172/JCI139080] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
20 Wang G, Wu M, Maloneyhuss MA, Wojcik J, Durham AC, Mason NJ, Roth DB. Actionable mutations in canine hemangiosarcoma. PLoS One 2017;12:e0188667. [PMID: 29190660 DOI: 10.1371/journal.pone.0188667] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
21 Chadwick ML, Lane A, Thomas D, Smith AR, White AR, Davidson D, Feng Y, Boscolo E, Zheng Y, Adams DM, Gupta A, Veillette A, Chow LML. Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma. Oncotarget 2018;9:24750-65. [PMID: 29872503 DOI: 10.18632/oncotarget.25345] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
22 Hoang NT, Acevedo LA, Mann MJ, Tolani B. A review of soft-tissue sarcomas: translation of biological advances into treatment measures. Cancer Manag Res 2018;10:1089-114. [PMID: 29785138 DOI: 10.2147/CMAR.S159641] [Cited by in Crossref: 51] [Cited by in F6Publishing: 23] [Article Influence: 17.0] [Reference Citation Analysis]
23 Luo L, Qin ZH. Autophagy, Aging, and Longevity. Adv Exp Med Biol 2019;1206:509-25. [PMID: 31777001 DOI: 10.1007/978-981-15-0602-4_24] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
24 Wang G, Wu M, Durham AC, Radaelli E, Mason NJ, Xu X, Roth DB. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma. PLoS One 2020;15:e0229728. [PMID: 32210430 DOI: 10.1371/journal.pone.0229728] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
25 García-Iglesias MJ, Cuevas-Higuera JL, Bastida-Sáenz A, de Garnica-García MG, Polledo L, Perero P, González-Fernández J, Fernández-Martínez B, Pérez-Martínez C. Immunohistochemical detection of p53 and pp53 Ser392 in canine hemangiomas and hemangiosarcomas located in the skin. BMC Vet Res 2020;16:239. [PMID: 32660487 DOI: 10.1186/s12917-020-02457-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Curylova L, Ramos H, Saraiva L, Skoda J. Noncanonical roles of p53 in cancer stemness and their implications in sarcomas. Cancer Lett 2022;525:131-45. [PMID: 34742870 DOI: 10.1016/j.canlet.2021.10.037] [Reference Citation Analysis]
27 Slotkin EK, Patwardhan PP, Vasudeva SD, de Stanchina E, Tap WD, Schwartz GK. MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma. Mol Cancer Ther 2015;14:395-406. [PMID: 25519700 DOI: 10.1158/1535-7163.MCT-14-0711] [Cited by in Crossref: 57] [Cited by in F6Publishing: 34] [Article Influence: 8.1] [Reference Citation Analysis]
28 Antonescu C. Malignant vascular tumors--an update. Mod Pathol. 2014;27 Suppl 1:S30-S38. [PMID: 24384851 DOI: 10.1038/modpathol.2013.176] [Cited by in Crossref: 111] [Cited by in F6Publishing: 89] [Article Influence: 15.9] [Reference Citation Analysis]
29 Marina M, Corcione L, Serra MF, Ferri T, Silini EM, Ceresini G. Primary Epithelioid Angiosarcoma of the Thyroid in a Patient Occupationally Exposed to Radiations. Front Endocrinol (Lausanne) 2018;9:577. [PMID: 30327639 DOI: 10.3389/fendo.2018.00577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
30 [DOI: 10.1101/741744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Gorden BH, Saha J, Khammanivong A, Schwartz GK, Dickerson EB. Lysosomal drug sequestration as a mechanism of drug resistance in vascular sarcoma cells marked by high CSF-1R expression. Vasc Cell 2014;6:20. [PMID: 25295160 DOI: 10.1186/2045-824X-6-20] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
32 Khan JA, Maki RG, Ravi V. Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment. JCO 2018;36:194-201. [DOI: 10.1200/jco.2017.74.9812] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]
33 Beca F, Krings G, Chen YY, Hosfield EM, Vohra P, Sibley RK, Troxell ML, West RB, Allison KH, Bean GR. Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis. Mod Pathol 2020;33:1518-26. [PMID: 32123305 DOI: 10.1038/s41379-020-0511-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
34 Heishima K, Mori T, Sakai H, Sugito N, Murakami M, Yamada N, Akao Y, Maruo K. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis. PLoS One 2015;10:e0137361. [PMID: 26335793 DOI: 10.1371/journal.pone.0137361] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
35 Andersen NJ, Nickoloff BJ, Dykema KJ, Boguslawski EA, Krivochenitser RI, Froman RE, Dawes MJ, Baker LH, Thomas DG, Kamstock DA, Kitchell BE, Furge KA, Duesbery NS. Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma. Mol Cancer Ther 2013;12:1701-14. [PMID: 23804705 DOI: 10.1158/1535-7163.MCT-12-0893] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
36 Amaya CN, Perkins M, Belmont A, Herrera C, Nasrazadani A, Vargas A, Khayou T, Montoya A, Ballou Y, Galvan D, Rivas A, Rains S, Patel L, Ortega V, Lopez C, Chow W, Dickerson EB, Bryan BA. Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma. Oncoscience 2018;5:109-19. [PMID: 29854879 DOI: 10.18632/oncoscience.413] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
37 Biswas B, Dabkara D. Bevacizumab in Advanced Angiosarcoma: What Is the Reality? J Clin Oncol 2016;34:764. [PMID: 26712219 DOI: 10.1200/JCO.2015.64.2181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
38 Du W, Gerald D, Perruzzi CA, Rodriguez-Waitkus P, Enayati L, Krishnan B, Edmonds J, Hochman ML, Lev DC, Phung TL. Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin. Lab Invest 2013;93:1115-27. [PMID: 23938603 DOI: 10.1038/labinvest.2013.98] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
39 Chen TW, Burns J, Jones RL, Huang PH. Optimal Clinical Management and the Molecular Biology of Angiosarcomas. Cancers (Basel) 2020;12:E3321. [PMID: 33182685 DOI: 10.3390/cancers12113321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Kunkiel M, Maczkiewicz M, Jagiełło-Gruszfeld A, Nowecki Z. Primary angiosarcoma of the breast-series of 11 consecutive cases-a single-centre experience. Curr Oncol 2018;25:e50-3. [PMID: 29507495 DOI: 10.3747/co.25.3816] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
41 Megquier K, Turner-Maier J, Swofford R, Kim JH, Sarver AL, Wang C, Sakthikumar S, Johnson J, Koltookian M, Lewellen M, Scott MC, Schulte AJ, Borst L, Tonomura N, Alfoldi J, Painter C, Thomas R, Karlsson EK, Breen M, Modiano JF, Elvers I, Lindblad-Toh K. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma. Mol Cancer Res 2019;17:2410-21. [PMID: 31570656 DOI: 10.1158/1541-7786.MCR-19-0221] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 15.5] [Reference Citation Analysis]
42 Thomas R, Borst L, Rotroff D, Motsinger-Reif A, Lindblad-Toh K, Modiano JF, Breen M. Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma. Chromosome Res 2014;22:305-19. [PMID: 24599718 DOI: 10.1007/s10577-014-9406-z] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
43 Guan H, Zhang L, Zhang Q, Qi W, Xie S, Hou J, Wang H. Primary angiosarcoma arising in an angiomyolipoma of the kidney: case report and literature review. Diagn Pathol 2018;13:53. [PMID: 30111336 DOI: 10.1186/s13000-018-0730-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
44 Richer M, Barkati M, Meunier C, Fortin S, Provencher D, Rahimi K. Vaginal epithelioid angiosarcoma: a potential pitfall in gynecologic pathology. J Low Genit Tract Dis 2014;18:E38-42. [PMID: 23994949 DOI: 10.1097/LGT.0b013e31829863b3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
45 Kim JH, Graef AJ, Dickerson EB, Modiano JF. Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives. Vet Sci 2015;2:388-405. [PMID: 29061949 DOI: 10.3390/vetsci2040388] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
46 Crafton SM, Senter-Jamieson L, Chen JL, Copeland LJ, Suarez AA. Radiation-associated Angiosarcoma Mimicking Fallopian Tube High-grade Serous Carcinoma in a Woman With De Novo Li-Fraumeni Syndrome. Int J Gynecol Pathol 2019;38:258-62. [PMID: 29620582 DOI: 10.1097/PGP.0000000000000502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Cioffi A, Reichert S, Antonescu CR, Maki RG. Angiosarcomas and other sarcomas of endothelial origin. Hematol Oncol Clin North Am 2013;27:975-88. [PMID: 24093171 DOI: 10.1016/j.hoc.2013.07.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
48 Calvete O, Garcia-Pavia P, Domínguez F, Mosteiro L, Pérez-Cabornero L, Cantalapiedra D, Zorio E, Ramón Y Cajal T, Crespo-Leiro MG, Teulé Á, Lázaro C, Morente MM, Urioste M, Benitez J. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas. J Am Heart Assoc 2019;8:e012875. [PMID: 31510873 DOI: 10.1161/JAHA.119.012875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Krishnamurthy A, Nayak D, Ramshankar V, Majhi U. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of primary pulmonary angiosarcomas. Indian J Nucl Med 2015;30:142-4. [PMID: 25829733 DOI: 10.4103/0972-3919.152977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Kessler SM, Leber B, Hoppstädter J, Golob-Schwarzl N, Hofer EM, Schultheiss CS, Mischinger HJ, Liegl-Atzwanger B, Lackner C, Stiegler P, Haybaeck J. Diethylnitrosamine (DENA) recapitulates formation of hepatic angiosarcoma in pigs. PLoS One 2019;14:e0214756. [PMID: 31095587 DOI: 10.1371/journal.pone.0214756] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Urbini M, Astolfi A, Indio V, Nannini M, Pizzi C, Paolisso P, Tarantino G, Pantaleo MA, Saponara M. Genetic aberrations and molecular biology of cardiac sarcoma. Ther Adv Med Oncol 2020;12:1758835920918492. [PMID: 32489430 DOI: 10.1177/1758835920918492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
52 Huang SC, Zhang L, Sung YS, Chen CL, Kao YC, Agaram NP, Singer S, Tap WD, D'Angelo S, Antonescu CR. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations. Am J Surg Pathol. 2016;40:645-655. [PMID: 26735859 DOI: 10.1097/pas.0000000000000582] [Cited by in Crossref: 79] [Cited by in F6Publishing: 35] [Article Influence: 15.8] [Reference Citation Analysis]
53 Hanna JA, Drummond CJ, Garcia MR, Go JC, Finkelstein D, Rehg JE, Hatley ME. Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma. Cancer Res 2017;77:6109-18. [PMID: 28916654 DOI: 10.1158/0008-5472.CAN-17-1262] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
54 Udager AM, Ishikawa MK, Lucas DR, McHugh JB, Patel RM. MYC immunohistochemistry in angiosarcoma and atypical vascular lesions: practical considerations based on a single institutional experience. Pathology 2016;48:697-704. [PMID: 27780597 DOI: 10.1016/j.pathol.2016.08.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
55 Wagner MJ, Ravi V, Menter DG, Sood AK. Endothelial cell malignancies: new insights from the laboratory and clinic. NPJ Precis Oncol 2017;1:11. [PMID: 29872699 DOI: 10.1038/s41698-017-0013-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
56 D'Angelo SP, Antonescu CR, Kuk D, Qin L, Moraco N, Carvajal RC, Chi P, Dickson MA, Gounder M, Keohan ML, Singer S, Schwartz GK, Tap WD. High-risk features in radiation-associated breast angiosarcomas. Br J Cancer 2013;109:2340-6. [PMID: 24104962 DOI: 10.1038/bjc.2013.590] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
57 Burns EA, Ahmed A, Sunkara A, Khan U, Sharif R, Abdelrahim M, Reardon M, Trachtenberg B. Primary cardiac angiosarcoma diagnosed in the first trimester of pregnancy. Ecancermedicalscience 2019;13:922. [PMID: 31281419 DOI: 10.3332/ecancer.2019.922] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]